Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
Nano-liquid chromatography-high-resolution tandem mass spectrometry (nano-LC-HRMS/MS) reveals saliva protein shifts before and after multiple sclerosis therapy.
Max Besenhard explains how hybrid mechanistic and machine learning models can make HPLC method development quicker, more robust and ready for autonomous digital twins.